Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Aramchol in Healthy Chinese Volunteers
NCT02803996Phase 1Completed
- Sponsor
- Galmed Pharmaceuticals
- Start
- May 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aramchol in Nonalcoholic steatohepatitis (NASH) (6 arms), sponsored by Galmed Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration and Area Under the Plasma Concentration Time Curve. Started May 2016; status: completed.
02
Drugs
aramchol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02803996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02803996.